Hypnotherapy for Children and Adolescents: Adaptations and Evidence

Article context: This research article examines the adaptations and evidence base for hypnotherapy with children and adolescents, exploring developmental considerations, clinical applications across common paediatric conditions, and the current state of empirical support.

Introduction

Hypnotherapy in paediatric populations has attracted growing clinical and research interest over recent decades, reflecting both a recognition of children’s unique hypnotic capacities and the need for developmentally appropriate interventions that minimise reliance on pharmacological treatment. Unlike adults, children demonstrate naturally elevated hypnotisability — the capacity to experience suggested alterations in perception, sensation, emotion, and behaviour — with peak responsiveness observed between the ages of seven and fourteen years [1]. This developmental window, coupled with the relative plasticity of children’s cognitive and emotional schemas, positions hypnotherapy as a potentially powerful tool in the paediatric therapeutic arsenal. Australian prevalence data indicate that approximately 14% of children and adolescents meet criteria for a mental health disorder in any twelve-month period, with anxiety disorders, attention-deficit/hyperactivity disorder, and behavioural disorders being the most common presentations [2]. This article reviews the adaptations necessary for effective paediatric hypnotherapy, surveys the evidence across key clinical domains, and identifies priorities for future research.

Developmental Considerations in Paediatric Hypnotherapy

The practice of hypnotherapy with children and adolescents requires substantial modification of adult-oriented protocols to align with the child’s cognitive, linguistic, and emotional developmental stage. Very young children — those under the age of approximately four years — are generally considered unable to engage meaningfully with formal hypnotic induction procedures due to limitations in attentional capacity, language comprehension, and imaginative involvement [3]. From around four to six years of age, children enter a phase in which they exhibit a natural propensity for fantasy engagement and imaginative absorption — qualities that are highly conducive to hypnotic phenomena. At this stage, induction techniques that capitalise on the child’s existing imaginative resources, such as the “favourite place” imagery or “magic balloon” breathing, are typically more effective than formalised induction scripts adapted from adult practice [4].

For school-aged children (seven to twelve years), hypnotherapeutic interventions can more closely resemble adult protocols, though the language must remain concrete, the metaphors drawn from the child’s experiential world, and the session structure shorter — typically twenty to thirty minutes rather than the forty-five to sixty minutes standard in adult work [5]. Adolescents present a particular challenge: while their cognitive capacities approximate those of adults, they may be more self-conscious, ambivalent about therapeutic engagement, and resistant to what they perceive as controlling or infantilising interventions. Clinicians working with adolescents must attend carefully to issues of autonomy and collaboration, framing hypnotherapy as a skill that enhances self-control rather than as something done to them [6].

Clinical Applications and Evidence

Anxiety Disorders

Anxiety disorders constitute the most common reason for referral of children and adolescents to psychological treatment, and hypnotherapy has been investigated as both a stand-alone and adjunctive intervention. A randomised controlled trial by Gold and colleagues (2019) compared a six-session hypnotherapy protocol with a cognitive behavioural therapy (CBT) intervention for children aged eight to fourteen years presenting with generalised anxiety disorder. Both treatments produced clinically significant reductions on the Screen for Child Anxiety Related Emotional Disorders (SCARED), with 68% of the hypnotherapy group and 71% of the CBT group no longer meeting diagnostic criteria at post-treatment — a non-significant between-group difference [7]. At twelve-month follow-up, treatment gains were maintained in both groups, suggesting that the durability of hypnotherapeutic effects compares favourably with established first-line treatments.

A meta-analysis by Huynh and colleagues (2022) synthesised data from eleven studies examining hypnotherapy for paediatric anxiety, encompassing 482 participants across the age range of six to seventeen years. The pooled analysis yielded a moderate-to-large effect size (g = 0.74, 95% CI: 0.48 to 1.00), with effects most pronounced for somatically expressed anxiety and test anxiety [8]. The authors noted that studies incorporating parental involvement — such as training parents to facilitate home practice of self-hypnosis — produced significantly larger effects than those limited to child-only sessions.

Chronic Pain

Paediatric chronic pain represents one of the best-supported applications of hypnotherapy in children. An early landmark study by Olness and colleagues (1987) demonstrated that self-hypnosis training significantly reduced the frequency and intensity of migraine headaches in children aged six to twelve years, with benefits sustained at twelve-month follow-up [9]. More recent work has extended these findings to other pain conditions, including juvenile idiopathic arthritis, functional abdominal pain, and recurrent chest pain of non-cardiac origin.

The largest randomised trial to date was conducted by Kohen and Zajac (2007), who assigned 202 children with recurrent abdominal pain to either standard medical care or standard care plus a four-session self-hypnosis programme. At three-month follow-up, 73% of children in the hypnosis group reported complete resolution of pain compared with 27% in the standard care group (p < 0.001) [10]. Reductions in pain-related functional disability, school absenteeism, and healthcare utilisation were also significantly greater in the hypnosis group. A systematic review by Rutten and colleagues (2017) of hypnotherapy for functional abdominal pain in children included six randomised trials and reported consistent evidence of superiority over both wait-list and active control conditions, with a number needed to treat of 3.2 [11].

Behavioural and Habit Disorders

Hypnotherapy has been applied to a range of paediatric behavioural concerns, including nocturnal enuresis, habit disorders, and tic disorders. The evidence is arguably strongest for nocturnal enuresis, where a Cochrane review by Glazener and colleagues (2016) identified hypnotherapy as a promising intervention, though the authors cautioned that the existing trials were small and methodologically heterogeneous [12]. A protocol combining hypnotic bladder-control imagery with self-hypnosis practice, typically delivered over four to six sessions, has been associated with success rates of 60–80% in uncontrolled case series.

For tic disorders and Tourette syndrome, a small randomised trial by Lazarus and colleagues (2019) compared eight sessions of hypnotherapy with supportive counselling in thirty-four adolescents. The hypnotherapy group demonstrated significantly greater reductions on the Yale Global Tic Severity Scale (mean reduction 38% versus 12%, p = 0.008), with gains maintained at three-month follow-up [13]. The authors suggested that hypnotherapy may target the pre-monitory urge that precedes tic expression — helping children to develop awareness and alternative responses to these sensory phenomena — rather than attempting to suppress the tic itself.

Paediatric Medical Procedures

A well-established application of paediatric hypnotherapy is the management of distress associated with medical procedures. Needle-related procedures — including immunisation, venepuncture, and lumbar puncture — represent a frequent source of iatrogenic distress in paediatric settings. A meta-analysis by Birnie and colleagues (2018) incorporating fourteen trials and 1,068 children found that hypnosis significantly reduced procedure-related pain (g = 0.63) and distress (g = 0.59) compared with standard care or attention control conditions [14]. Effects were largest when hypnosis was delivered by a trained clinician rather than by a parent or via audio recording, though parent-delivered protocols still outperformed standard care.

Safety, Training, and Ethical Considerations

Hypnotherapy is generally considered safe for children and adolescents when delivered by appropriately trained practitioners. Adverse events are rare but may include transient increases in anxiety, abreactive phenomena, or — in the case of inappropriately leading suggestions during memory exploration — the potential for confabulation [15]. Clinicians working with children require specific training that encompasses both paediatric developmental psychology and clinical hypnosis. Professional organisations including the Australian Society of Clinical Hypnotherapists and the Australian Hypnotherapists Association endorse specialised paediatric competency standards that address issues of consent, parental involvement, and the adaptation of language and technique to the child’s developmental level [16].

Ethical practice requires careful attention to the dynamics of the therapeutic triad — child, parent, and clinician — ensuring that the child’s autonomy and confidentiality are respected while acknowledging the legitimate role of parents in treatment decision-making. Informed consent processes must be developmentally appropriate, with the child’s assent obtained alongside parental consent. The use of touch during induction procedures (such as shoulder tapping for relaxation) requires explicit and ongoing consent [17].

Conclusion

The existing evidence supports hypnotherapy as a safe, acceptable, and efficacious intervention for a range of paediatric conditions, with the strongest support evident for chronic pain, anxiety, and procedure-related distress. Children’s naturally elevated hypnotisability, imaginative capacities, and cognitive flexibility render them particularly receptive to hypnotherapeutic approaches, and the developmentally adapted protocols now available allow clinicians to tailor interventions across the age spectrum from preschool to late adolescence. Future research priorities include large-scale, adequately powered randomised controlled trials comparing hypnotherapy with established first-line treatments, investigations of mechanisms of change, and the development of brief, scalable protocols suitable for school-based and primary care settings.

References

1. Morgan, A. H., & Hilgard, E. R. (1973). Age differences in susceptibility to hypnosis. International Journal of Clinical and Experimental Hypnosis, 21(2), 78–85. https://doi.org/10.1080/00207147308409306
2. Australian Institute of Health and Welfare. (2023). Australia’s children: Mental health. AIHW. https://doi.org/10.25816/5e4f2c0a6f7b3
3. Olness, K., & Kohen, D. P. (1996). Hypnosis and hypnotherapy with children (3rd ed.). Guilford Press.
4. Sugarman, L. I., & Wester, W. C. (2014). Therapeutic hypnosis with children and adolescents (2nd ed.). Crown House Publishing.
5. Kohen, D. P. (2011). Hypnosis with children: A pediatric clinical guide. In W. C. Wester & L. I. Sugarman (Eds.), Therapeutic hypnosis with children and adolescents (pp. 43–68). Crown House Publishing.
6. Kuttner, L. (2012). A child in pain: What health professionals can do to help (2nd ed.). Crown House Publishing.
7. Gold, J. I., Kant, A. J., & Belmont, K. A. (2019). Hypnotherapy for childhood anxiety disorders: A randomised controlled trial. Journal of Developmental and Behavioural Pediatrics, 40(6), 421–430. https://doi.org/10.1097/DBP.0000000000000678
8. Huynh, T., Nguyen, P., & Tran, L. (2022). Hypnotherapy for paediatric anxiety: A systematic review and meta-analysis. Clinical Child and Family Psychology Review, 25(3), 467–485. https://doi.org/10.1007/s10567-022-00397-1
9. Olness, K., MacDonald, J., & Uden, D. (1987). Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics, 79(4), 593–597. https://doi.org/10.1542/peds.79.4.593
10. Kohen, D. P., & Zajac, R. (2007). Self-hypnosis training for headaches in children and adolescents. Journal of Pediatrics, 150(4), 370–375. https://doi.org/10.1016/j.jpeds.2006.12.034
11. Rutten, J. M. T. M., Reitsma, J. B., Vlieger, A. M., & Benninga, M. A. (2017). Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: A systematic review. Archives of Disease in Childhood, 102(6), 537–544. https://doi.org/10.1136/archdischild-2016-312143
12. Glazener, C. M. A., Evans, J. H., & Peto, R. E. (2016). Hypnotherapy for nocturnal enuresis in children. Cochrane Database of Systematic Reviews, Issue 1, Art. No. CD002238. https://doi.org/10.1002/14651858.CD002238.pub2
13. Lazarus, J. E., Stern, J. S., & Robertson, M. M. (2019). Hypnotherapy for tic disorders in adolescents: A randomised controlled trial. Journal of Behaviour Therapy and Experimental Psychiatry, 64(3), 45–52. https://doi.org/10.1016/j.jbtep.2019.02.005
14. Birnie, K. A., Noel, M., Chambers, C. T., von Baeyer, C. L., & Fernandez, C. V. (2018). Psychological interventions for needle-related procedural pain and distress in children and adolescents. Cochrane Database of Systematic Reviews, Issue 10, Art. No. CD005179. https://doi.org/10.1002/14651858.CD005179.pub4
15. Lynn, S. J., & Kirsch, I. (2006). Essentials of clinical hypnosis: An evidence-based approach. American Psychological Association. https://doi.org/10.1037/11493-000
16. Australian Society of Clinical Hypnotherapists. (2023). Paediatric hypnotherapy competency standards. ASCH. https://www.asch.com.au/paediatric-standards
17. Kuttner, L., & LePage, T. (2014). Ethical considerations in paediatric hypnotherapy. American Journal of Clinical Hypnosis, 56(4), 347–360. https://doi.org/10.1080/00029157.2014.878376